News
-
-
-
-
-
-
COMMUNIQUÉ DE PRESSE
Study Shows hTERT Vaccination Induces Immunological Responses and Prevents Progression in a Subset of Therapy-Resistant Poor Prognosis Cancer Patients
A Phase 1 clinical trial led by James Spicer at King's College London showcases promising developments in immune therapy for solid tumours via hTERT vaccination. Published in Experimental Biology and Medicine